# M2S Korea

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/m2s-korea

- Industry: Healthcare IT
- Headquarters: Gangnam-gu, South Korea
- Website: www.m2skorea.com
- Total disclosed funding: $5.3M
- Latest round: Series A (Mar 7, 2022)
- Investors on record: 4

## About

M2S Korea, located in South Korea, specializes in eye care solutions using advanced healthcare technology, particularly in the realm of virtual reality for improved medical diagnostics and treatment.Founded in 2017 and based in Gangnam-gu, South Korea, M2S Korea focuses on developing innovative eye-related healthcare solutions. The company has successfully completed 4 deals, with its most recent funding round, Series A, raising KRW 6.5 billion on March 7, 2022, from investors such as CHA HEALTHCARE CO., LTD., SK Securities, and Shinhan Capital. The CEO of the company is Taehwi Lee, alongside Won Jung.M2S Korea develops extended reality (XR) healthcare solutions, primarily leveraging virtual reality (VR) technology to enhance medical diagnostics and treatment for various eye conditions. Their primary product offerings include advanced VR head-mounted displays (HMDs) designed to provide immersive experiences that facilitate effective diagnosis and treatment, thus improving patient compliance and engagement. The company markets its products primarily in the Asia-Pacific region, with a strong presence in South Korea and plans to expand into other international markets.M2S generates revenue through partnerships with healthcare providers and institutions, offering subscription-based access to their XR healthcare products. This business model allows seamless integration of VR technologies into medical practices, with revenue derived from direct sales to healthcare facilities and potential collaborations with research institutions. Their pricing strategies aim to provide value to both large healthcare entities and individual practitioners, ensuring accessibility to their technology.In March 2022, M2S raised KRW 6.5 billion in Series A funding to enhance its VR technology-based digital healthcare solution platform and recruit additional talent. The company plans to develop new products aimed at improving the treatment of eye conditions and is targeting expansion into new geographic markets beyond South Korea. Recent funding will support these initiatives by upgrading their technology and scaling operations to meet the demands of healthcare providers globally.

## Funding rounds

- Series A, Mar 7, 2022, $5.3M — Shinhan Capital, Solidus Investment, SK Securities, CHA HEALTHCARE CO., LTD.

## Investors

- Shinhan Capital (https://capitalatlas.ai/funds/shinhan-capital) — Series A
- Solidus Investment (https://capitalatlas.ai/funds/solidus-investment) — Series A
- SK Securities — Series A
- CHA HEALTHCARE CO., LTD. — Series A